RLMD
Relmada Therapeutics Inc
Price:
0.64
USD
Volume:
742,653
United States | Pharmaceuticals
RLMD Current Ratio
As of 2025-05-25, the Current Ratio of Relmada Therapeutics Inc (RLMD) is 4.45.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
RLMD Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 4.45 |
| 2023-12-31 | 8 |
| 2022-12-31 | 12.23 |
| 2021-12-31 | 14.79 |
| 2020-12-31 | 9.37 |
| 2019-06-30 | 3.85 |
| 2018-06-30 | 0.46 |
| 2017-06-30 | 1.79 |
| 2016-06-30 | 3 |
| 2015-06-30 | 1.54 |
RLMD Current Ratio - Peers Comparison